Jeffrey R. Dahlen

University of Tübingen — Germany

Medicine · Health Sciences

14h-index815citations34works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Antiplatelet Therapy and Cardiovascular Diseases(10), Protease and Inhibitor Mechanisms(8), Venous Thromboembolism Diagnosis and Management(6), Atrial Fibrillation Management and Outcomes(5), Blood Coagulation and Thrombosis Mechanisms(4)

Publications34 total

Abstract 728: Identification of high-risk luminal early breast cancer patients based on a p53 signature
Cancer Research·2025
Differential inhibition of platelet function by cilostazol in combination with clopidogrel
European Journal of Clinical Pharmacology·2023
Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases
Critical Care Explorations·2023· 6 citedOpen Access
Urinary L-Type Fatty Acid-Binding Protein Predicts Oxygen Demand of COVID-19 in Initially Mild Cases
SSRN Electronic Journal·2022· 2 citedOpen Access
Clinical Utility of a Biomarker to Detect Contrast-Induced Acute Kidney Injury during Percutaneous Cardiovascular Procedures
Cardiorenal Medicine·2022· 10 citedOpen Access
Abstract 12380: 1,5-anhydroglucitol is a Novel and Independent Predictor of Mortality in Patients With COVID-19
Circulation·2021
Clinical validation of AggreGuide A-100 ADP, a novel assay for assessing the antiplatelet effect of oral P2Y12 antagonists
Journal of Thrombosis and Thrombolysis·2021· 2 cited
First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19
Open Forum Infectious Diseases·2021· 30 citedOpen Access
Measuring the Variation in the Prevention and Treatment of CI-AKI Among Interventional Cardiologists
Current Problems in Cardiology·2021· 5 cited
The Total Thrombus Formation (T-TAS) platelet (PL) assay, a novel test that evaluates whole blood platelet thrombus formation under physiological conditions
Platelets·2021· 14 citedOpen Access
New methodological approaches for assessing thrombus formation in cardiovascular disease
Kardiologia Polska·2020· 4 citedOpen Access
Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners
Journal of Clinical & Translational Endocrinology·2020· 3 citedOpen Access
NOVEL METHOD FOR ASSESSING PLATELET RESPONSE TO ADP: TECHNICAL VALIDATION STUDY OF THE AGGREGUIDE A-100 ADP ASSAY
Journal of the American College of Cardiology·2020
Total Thrombus-Formation Analysis System (T-TAS): Clinical Application of Quantitative Analysis of Thrombus Formation in Cardiovascular Disease
Thrombosis and Haemostasis·2019· 72 citedOpen Access
Variation in Diabetes Management: A National Assessment of Primary Care Providers
Journal of Diabetes Science and Technology·2019· 5 citedOpen Access
1227-P: GlycoMark 1,5-Anhydrocluitol Values in Patients Taking SGLT2 Inhibitors
Diabetes·2019
ANTARCTIC: platelet function testing to adjust therapy
The Lancet·2017· 3 citedOpen Access
Cigarette Smoking, Clopidogrel Responsiveness, and Hemoglobin Level
JACC: Cardiovascular Interventions·2016
Evaluating the clinical usefulness of platelet function testing: Considerations for the proper application and interpretation of performance measures
Thrombosis and Haemostasis·2012· 34 cited
A Unique and Comprehensive Approach to Quality Control
Point of Care The Journal of Near-Patient Testing & Technology·2011
page 1 of 2Next →

Frequent Co-authors

Donald C. Foster(8), Udaya S. Tantry(7), Kevin P. Bliden(7), Paul A. Gurbel(7), Walter Kisiel(6), John Peabody(4), David Paculdo(4), Eisei Noiri(4), Takeshi Sugaya(4), Cindy A. Sprecher(3), Kazuya Hosokawa(3), Maria Czarina Acelajado(3), Robert V. Talanian(2), Matthew J. Price(2), Walter Kisiel(2), Czarlota Valdenor(2), Peter A. McCullough(2), Norio Ohmagari(2), Masahiro Ishikane(2), Sayaka Hikida(2)